Also trades as: HEMO.L (LSE) · $vol 0M
HOPHF OTC
Hemogenyx Pharmaceuticals Plc
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -97.1%
5Y: -80.1%
$2.33
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4M
+32.2% ▲
Capital Expenditures
$13K
+88.7% ▲
5Y CAGR: +2.2%
Free Cash Flow
-$4M
+33.3% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$1M
+15.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | -$5M | -$4M | -$7M | -$6M |
| Depreciation & Amort. | $107K | $126K | $195K | $646K | $639K |
| Stock-Based Comp. | $363K | $153K | $18K | $243K | $344K |
| Change in Working Capital | -$57K | $101K | $243K | -$834K | $256K |
| Other Non-Cash Items | $30K | $2M | $617K | $536K | $246K |
| Operating Cash Flow | -$2M | -$3M | -$3M | -$6M | -$4M |
| — Investing Activities — | |||||
| Capital Expenditures | -$173K | -$818K | -$429K | -$117K | -$13K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | -$139K | -$2K | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $3K | $18K | $11K | $85K | $12K |
| Investing Cash Flow | -$170K | -$939K | -$420K | -$32K | -$2K |
| — Financing Activities — | |||||
| Net Debt Issuance | $4M | $9M | $0 | $0 | -$635K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$433K | -$39K | -$110K | -$639K | -$932K |
| Financing Cash Flow | $3M | $9M | -$110K | $4M | $3M |
| Net Change in Cash | $1M | $5M | -$4M | -$1M | -$1M |
| Cash End of Period | $2M | $7M | $3M | $1M | $159K |
| Free Cash Flow | -$2M | -$3M | -$3M | -$6M | -$4M |